MIMEDX GROUP, INC. MDXG
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-08-20
MIMEDX GROUP, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 82.6% | 82.8% | 83.0% | 82.0% | 83.6% |
| Operating margin | 15.3% | 16.9% | 11.5% | -5.5% | -2.9% |
| Net margin | 11.6% | 12.2% | 18.1% | -11.3% | -4.2% |
| FCF margin | — | — | 10.2% | -7.2% | -5.4% |
| Return on assets | 14.2% | 16.1% | 24.4% | -17.6% | -5.5% |
| Return on equity | 18.9% | 22.0% | 40.8% | 167.9% | -12542.7% |
| Debt / equity | 0.07× | 0.10× | 0.35× | -2.78× | 609.76× |
| Current ratio | 4.32 | 4.21 | 3.57 | 3.08 | 3.51 |
| Revenue growth | 20.0% | 8.5% | 20.0% | 10.7% | -2.5% |
Source: SEC EDGAR filings · CIK 0001376339 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.